The effort to make a breakthrough cancer therapy cheaper
CAR-T cells could revolutionize the treatment of a wide variety of diseases, if only we can make them cheaper.
Stay updated with breaking news from Caring Cross. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAR-T cells could revolutionize the treatment of a wide variety of diseases, if only we can make them cheaper.
Today's biotech news includes a potentially major drug approval, an idea to make CAR-T more equitable, and the slow launch of a gene therapy.
Brazil’s Ministry of Health and nonprofit Caring Cross announced a collaboration Tuesday aimed at local manufacturing of CAR-T cell and stem cell gene therapies at a much lower cost than Europe and the U.S.
UC Davis exceeded $1 billion in new external research awards in the fiscal year 2022-23 following the record set the previous year.
/PRNewswire/ -- The Maryland Stem Cell Research (MSCRF) Commission is pleased to announce over $14.1 million in grant awards to promote innovative research...